1216 Fin QTs
BioCentury & Getty Images

Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

Dec 17, 2020 | 2:46 AM GMT

Megaround for gene therapy play Neurogene
Neurogene Inc. raised $115 million in a series B round led by EcoR1 Capital, with participation by existing

Read the full 524 word article

How to gain access

Continue reading with a
two-week free trial.